Availability of Orkambi on the NHS inquiry

Friday 30 November 2018 - Friday 30 November 2018

Publications

RSS

• Letter from Vertex, regarding the availability of Orkambi on the NHS, 24 October 2019

  Thursday 24 October 2019 @ 14:00

• Letter to the Chair of the Committee from NHS England, regarding cystic fibrosis drugs, 24 October 2019

  Thursday 24 October 2019 @ 11:00

• Letter from NICE regarding update on the progress of negotiations on the availability of Orkambi for NHS patients in England, 30 May 2019

  Thursday 30 May 2019 @ 12:00

• Letter from Vertex Pharmaceuticals regarding update on the progress of negotiations on the availability of Orkambi for NHS patients in England, 23 May 2019

  Thursday 23 May 2019 @ 17:00

• Letter from NHS England regarding update on the progress of negotiations on the availability of Orkambi for NHS patients in England, 23 May 2019

  Thursday 23 May 2019 @ 12:00

• Letter to the Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care regarding the availability of Orkambi on the NHS

  Wednesday 13 March 2019 @ 10:15

• Documents from Vertex Pharmaceutical (Europe) Ltd, 16 January 2019

  Wednesday 30 January 2019 @ 18:00

• Letter from NICE to Vertex dated, 13 December 2018

  Wednesday 30 January 2019 @ 18:00

• Letter from Vertex to NHSE dated, 16 January 2019

  Wednesday 30 January 2019 @ 18:00

• Letter from Vertex to NICE dated, 16 January 2019

  Wednesday 30 January 2019 @ 18:00

• Document from NHS England, 16 January 2018

  Wednesday 30 January 2019 @ 17:30

• Document from NHS England, 16 January 2018

  Wednesday 30 January 2019 @ 17:30

• Document from NICE, 15 January 2019

  Wednesday 30 January 2019 @ 17:30

• Submission from the parents of a young child with Cystic Fibrosis

  Thursday 20 December 2018 @ 18:00

• Submission from European Association of Bioindustries

  Thursday 20 December 2018 @ 18:00

• Submission from UK BioIndustry Association

  Thursday 20 December 2018 @ 18:00

• Documents from Vertex Pharmaceuticals, 30 November 2018

  Thursday 20 December 2018 @ 17:30

• Letter from the Chair requesting documents from NHS England, the National Institute for Health and Care Excellence (NICE) and Vertex Pharmaceuticals, 7 November 2018

  Thursday 20 December 2018 @ 17:00

• Documents from NHS England, 28 November 2018

  Thursday 20 December 2018 @ 17:00

• Documents from the National Institute for Health and Care Excellence (NICE), 29 November 2018

  Thursday 20 December 2018 @ 17:00

• Letters relating to availability of Orkambi for treatment of cystic fibrosis on the NHS, 7 November 2018

  Friday 9 November 2018 @ 10:30

• Correspondence with the Secretary of State relating to Orkambi and cystic fibrosis

  Monday 25 June 2018 @ 11:30